Amorphis Pharma Development Overview
- Year Founded
-
2018

- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Amorphis Pharma Development General Information
Description
Developer of amorphous drugs designed to have increased effectiveness as compared to drugs in oral solid forms. The company specializes in the amorphization and stabilization of pharmaceutically active substances to create drugs from the added-value medicines segment, that have good characteristics compared to the originals, enabling healthcare providers to improve the comfort of therapy rendered to patients by administering drugs in a stable amorphous form.
Contact Information
Website
www.amorphispharma.comCorporate Office
- Bankowa 12 lok 147
- Katowice, 40-007
- Poland
Corporate Office
- Bankowa 12 lok 147
- Katowice, 40-007
- Poland
Amorphis Pharma Development Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Accelerator/Incubator | 02-Mar-2023 | Completed | Generating Revenue | |||
1. Seed Round | 01-Jan-2019 | Completed | Startup |
Amorphis Pharma Development Comparisons
Industry
Financing
Details
Amorphis Pharma Development Competitors (3)
One of Amorphis Pharma Development’s 3 competitors is Ascendia Pharmaceuticals, a Private Equity-Backed company based in North Brunswick, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ascendia Pharmaceuticals | Private Equity-Backed | North Brunswick, NJ | ||||
Adare Pharma Solutions | Private Equity-Backed | Lawrenceville, NJ | ||||
Lonza Group | Corporation | Basel, Switzerland |
Amorphis Pharma Development Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
StartSmart CEE | Accelerator/Incubator | |||
INNOventure (Poland) | Venture Capital | Minority |
Amorphis Pharma Development FAQs
-
When was Amorphis Pharma Development founded?
Amorphis Pharma Development was founded in 2018.
-
Where is Amorphis Pharma Development headquartered?
Amorphis Pharma Development is headquartered in Katowice, Poland.
-
What industry is Amorphis Pharma Development in?
Amorphis Pharma Development’s primary industry is Drug Discovery.
-
Is Amorphis Pharma Development a private or public company?
Amorphis Pharma Development is a Private company.
-
What is Amorphis Pharma Development’s current revenue?
The current revenue for Amorphis Pharma Development is
. -
How much funding has Amorphis Pharma Development raised over time?
Amorphis Pharma Development has raised $265K.
-
Who are Amorphis Pharma Development’s investors?
StartSmart CEE and INNOventure (Poland) have invested in Amorphis Pharma Development.
-
Who are Amorphis Pharma Development’s competitors?
Ascendia Pharmaceuticals, Adare Pharma Solutions, and Lonza Group are competitors of Amorphis Pharma Development.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »